Experience

David Will

    • Braze – $572 Million IPO 


    • Exscientia – $510.4 Million IPO 


    • Molecular Partners – $64 Million IPO 


    • Finch Therapeutics – $128 Million IPO 


    • LAVA Therapeutics – $107 Million IPO 


    • Advises Anchiano Therapeutics Ltd on its reverse-merger with Chemomab